Plasma pancreatic stone protein is a promising biomarker for prognosis and severity outcome in sepsis patients with COVID-19

Abstract Sepsis and coronavirus disease 2019 (COVID-19) are life-threatening clinical syndromes with high mortality rate. This study aimed to investigate pancreatic stone protein (PSP) role as potential biomarker for sepsis/COVID-19 prognostication. Herein, based on the novel amplified luminescent p...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Hozeifa Mohamed Hassan, Rongzhi Liu, Yuhang Lv, Yanyun Ruan, Shaoyin Bao, Yulin Fu, Shuanshuan Liu, Lin Wang, Tianjun Pan, Qi Chen, Xueping Lou, Biao Huang, Zhencang Zheng
Format: Article
Language:English
Published: Nature Portfolio 2025-10-01
Subjects:
Hyper-inflammation
Sepsis
COVID-19
PSP
Disease prognosis
Severity outcome
Online Access:https://doi.org/10.1038/s41598-025-09750-0

Internet

https://doi.org/10.1038/s41598-025-09750-0

Similar Items